NCT02430779

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms: Phase I and Phase II Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Fuda Cancer Hospital, Guangzhou · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Renal Pelvic and Ureteral Neoplasms.

Detailed description

By enrolling patients with unresectable Renal Pelvic and Ureteral Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Renal Pelvic and Ureteral Neoplasms.

Conditions

• Renal Pelvic and Ureteral Neoplasms

Interventions

Type	Name	Description
PROCEDURE	rreversible electroporation (IRE)	Irreversible Electroportion For Unresectable Renal Pelvic and Ureteral Neoplasms guide with ultrasound or/and CT.
DEVICE	NanoKnife

Timeline

• Start date: 2015-01-01
• Primary completion: 2020-12-01
• Completion: 2021-01-01
• First posted: 2015-04-30
• Last updated: 2021-09-05

Locations

1 site across 1 country: China